Multiple Sclerosis at the Limits 2025

 
London, UK
 
Wednesday 10 & Thursday 11 December 2025 

Roche

Roche Products Ltd has provided financial support for this meeting but had no involvement in the agenda other than the stated Roche organised presentation.

Sanofi

Sanofi has supported this meeting through financial sponsorship and has had no control or input into the education content of this activity, nor the logistics elements, i.e. travel, accommodation, catering, venue selection or any other aspect of the meeting.

Novartis

Novartis has contributed to the funding of this meeting by way of sponsorship and has had no control or input into the educational content of this activity, nor the logistics elements, i.e. travel, accommodation, catering, venue selection or any other aspect of the meeting.

Juvisé

Juvisé has supported this meeting through financial sponsorship and has had no involvement in the development of the agenda or educational content, nor in the logistical arrangements such as travel, accommodation, catering, or venue selection. The only exception is the clearly identified Juvisé-organised presentation.

Disclosure of funders is made once contracts are signed and pre-event obligations such as payment have been completed.

Contact us 

If you require any assistance, please contact us